169 related articles for article (PubMed ID: 35822330)
1. Effect of Helicobacter pylori eradication therapy on the response of MALT-Gastric lymphoma.
Dabbebi H; Elloumi H; Kechiche C; Hammemi E; Cheikh I; Jmaa A
Tunis Med; 2022 Janvier; 100(1):37-43. PubMed ID: 35822330
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
3. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
Kuo SH; Yeh KH; Wu MS; Lin CW; Hsu PN; Wang HP; Chen LT; Cheng AL
Blood; 2012 May; 119(21):4838-44; quiz 5057. PubMed ID: 22403257
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis.
Xie YL; He CY; Wei SQ; Guan WJ; Jiang Z
Chin Med J (Engl); 2020 Jun; 133(11):1337-1346. PubMed ID: 32452892
[TBL] [Abstract][Full Text] [Related]
6. Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma.
Kadota H; Yuge R; Miyamoto R; Otani R; Takigawa H; Hayashi R; Urabe Y; Oka S; Sentani K; Oue N; Kitadai Y; Tanaka S
Helicobacter; 2022 Jun; 27(3):e12887. PubMed ID: 35363918
[TBL] [Abstract][Full Text] [Related]
7. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
8. Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?
Nonaka K; Ohata K; Matsuhashi N; Shimizu M; Arai S; Hiejima Y; Kita H
Dig Endosc; 2014 May; 26(3):358-64. PubMed ID: 24118642
[TBL] [Abstract][Full Text] [Related]
9. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.
El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM
Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
11. [Gastric MALT lymphoma and Helicobacter pylori].
Accardo D; Apuzzo M; Bazuro ME; Ferrara M; Tammaro G; Pippa G
Recenti Prog Med; 2000 Apr; 91(4):181-5. PubMed ID: 10804751
[TBL] [Abstract][Full Text] [Related]
12. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
[TBL] [Abstract][Full Text] [Related]
13. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
14. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
15. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
16. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome.
Diz-Lois Palomares MT; Souto Ruzo J; Yáñez López JA; Alvarez García A; Arnal Monreal F; Vázquez-Iglesias JL
Rev Esp Enferm Dig; 2002 Nov; 94(11):669-78. PubMed ID: 12690990
[TBL] [Abstract][Full Text] [Related]
17. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
18. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease.
Raderer M; Osterreicher C; Machold K; Formanek M; Fiebiger W; Penz M; Dragosics B; Chott A
Ann Oncol; 2001 Jul; 12(7):937-9. PubMed ID: 11521798
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
